Related Experiment Video
Updated: Jul 13, 2026

Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats
Published on: January 10, 2019
Evaluation of early retinal changes in patients on long-term hydroxychloroquine using optical coherence tomography
Huanhuan Zhao1,2, Menglu Pan1, Yaping Liu3,4
1Department of Rheumatology, First Affiliated Hospital of Anhui Medical University, Hefei, China.
Insights
Long-term hydroxychloroquine (HCQ) use in connective tissue diseases (CTD) correlates with retinal vascular changes, detectable by OCTA. However, HCQ concentrations in blood did not show a direct association with these OCTA-measured retinal changes.
Area of Science:
- Ophthalmology
- Rheumatology
- Pharmacology
Background:
- Connective tissue diseases (CTD), such as lupus and rheumatoid arthritis, are often treated with hydroxychloroquine (HCQ).
- Prolonged HCQ use can lead to adverse effects, notably retinopathy, necessitating monitoring for early detection of retinal changes.
Purpose of the Study:
- To identify early retinal alterations using optical coherence tomography angiography (OCTA) in CTD patients undergoing long-term HCQ treatment.
- To investigate the correlation between OCTA parameters and serum concentrations of HCQ and its metabolites.
Main Methods:
- A cross-sectional study involved 43 CTD patients treated with HCQ for over 6 months.
- OCTA was used to measure foveal avascular zone (FAZ) dimensions, macular thickness, and vascular density in the superficial (SCP) and deep (DCP) capillary plexuses.
- Serum concentrations of HCQ and its metabolites were quantified using high-performance liquid chromatography-tandem mass spectrometry.
Main Results:
- Cumulative HCQ duration and dose positively correlated with increased FAZ area and perimeter, and negatively with foveal vessel density in both SCP and DCP.
- No significant correlation was found between OCTA findings and patient age, disease duration, or weight-adjusted HCQ dose.
- OCTA outcomes did not correlate with measured blood concentrations of HCQ or its metabolites.
Conclusions:
- OCTA is a valuable tool for detecting microvascular changes in the macula of CTD patients on long-term HCQ therapy.
- Current findings suggest that serum concentrations of HCQ and its metabolites are not directly associated with the observed retinal vascular changes.
Background:
Connective tissue diseases (CTD), including systemic lupus erythematosus and rheumatoid arthritis (RA), have long been treated with hydroxychloroquine (HCQ). However, prolonged HCQ use poses a risk of adverse effects, particularly retinopathy.
Objective:
To detect early retinal changes assessed by optical coherence tomography angiography (OCTA) in CTD patients with long-term HCQ treatment and to explore the relationship between OCTA parameters and the concentrations of HCQ and its metabolites.
Design:
A cross-sectional study conducted from March 2020 to October 2021 at the First Affiliated Hospital of Anhui Medical University.
Methods:
The area and perimeter of the foveal avascular zone (FAZ), the thickness of the fovea and parafovea, and the vascular density of the superficial capillary plexus (SCP) and deep capillary plexus (DCP) in each area of the macula were measured by OCTA in 43 CTD patients treated with HCQ for over 6 months. Meantime, blood concentrations of HCQ and its metabolites were determined by high-performance liquid chromatography-tandem mass spectrometry, and the clinical documents of all 43 involved patients were collected.
Results:
There is no significant correlation between OCTA outcomes and the patient's age, disease duration, and weight-dependent dose. HCQ cumulative duration positively correlated with FAZ area and perimeter (r = 0.419, p = 0.005 and r = 0.407, p = 0.007, respectively) and negatively correlated with the foveal vessel density in DCP (r = -0.378, p = 0.012). HCQ cumulative dose had a positive correlation with FAZ area and perimeter (r = 0.445, p = 0.003 and r = 0.434, p = 0.004, respectively) and had a negative correlation with foveal vessel density in SCP and DCP (r = -0.383, p = 0.011 and r = -0.424, p = 0.005, respectively). OCTA outcomes did not correlate with HCQ and its metabolite concentrations.
Conclusion:
OCTA could be used to detect microvascular changes in the macula of CTD patients with long-term HCQ therapy. It was not found the concentrations of HCQ and its metabolites were associated with retinal vascular changes.
More Related Videos
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Diabetic Retinopathy

